Abstract
Background
Previous reports have shown that epithelial-to-mesenchymal transition (EMT) indicates the importance of transforming growth factor-13 (TGF-β) signalling in the pathogenesis of systemic sclerosis (SSc). However, the underlying molecular mechanisms of EMT are not fully understood.
Objectives
Brachyury, an evolutionarily conserved transcription factor, was recently identified as an important factor that promotes EMT in human carcinoma cell lines. However, there is no evidence indicating that brachyury is involved in EMT in SSc.
Materials and Methods
The expression of brachyury and collagen was investigated in cultures of dermal fibroblasts and skin sections derived from SSc patients and healthy controls. Brachyury and collagen expression were determined by immunohistochemistry and immunoblotting, respectively, and inRNA for both was analysed using real-time PCR.
Results
Brachyury was overexpressed in SSc dermal fibroblasts both in vivo and in vitro, and this overexpression was inhibited by TGF-β1 inhibitor. Brachyury siRNA reduced mRNA and protein expression levels of type I collagen in normal and SSc dermal fibroblasts, but did not decrease the levels of major disease-related cytokines. Furthermore, brachyury levels were significantly increased in skin samples of SSc patients relative to healthy controls.
Conclusions
The up-regulation of brachyury in response to activated endogenous TGF-β signalling may play a role in constitutive up-regulation of collagen in SSc fibroblasts. Further studies assessing the regulatory mechanism of tissue fibrosis induced by brachyury in SSc skin may lead to a better understanding of the pathogenesis, new diagnostic methods, and new therapeutic approaches using siRNAs.
Similar content being viewed by others
References
LeRoy EC. Increased collagen synthesis by scleroderma skin fibrob-lasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974; 54: 880–9.
Jimenez SA, Feldman G, Bashey RI, et al. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis. Biochem J 1986; 237: 837–43.
Massagué J. Transforming growth factor-β family. Ann Rev Celi Biol 1990; 6: 597–641.
LeRoy EC, Smith EA, Kahaleh MB, et al. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor β the answer? Arthritis Rheum 1989; 32: 817–25.
Wang Z, Jinnin M, Nakamura K, et al. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization. Exp Dermatol 2016; 25: 131–6.
Kikuchi K, Hartl CW, Smith EA, et al. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts. Biochem Biophys Res Commun 1992; 187: 45–50.
Ihn H, Yamane K, Kubo M, et al. Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor β receptors. Arthritis Rheum 1974; 44: 474–80.
Asano Y, Ihn H, Yamane K, et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts. J Clin Invest 2004; 113: 253–64.
Asano Y, Ihn H, Yamane K, et al. Phosphatidylinositol 3-kinase is involved in α2(1) collagen gene expression in normal and scleroderma fibroblasts. J Immunol 2004; 172: 7123–35.
Herrmann BG, Labeit S, Poustka A, et al. Cloning of the T gene required in mesoderm formation in the mouse. Nature 1990; 343: 617–22.
Kispert A, Herrmann BG. The Brachyury gene encodes a novel DNA binding protein. EMBO J 1993; 12: 3211–20.
Kispert A, Herrmann BG, Leptin M, et al. Homologs of the mouse Brachyury gene are involved in the specification of posterior terminal structures in Drosophila, Tribolium, and Locusta. Genes Dev 1994; 8: 2137–50.
Behr R, Heneweer C, Viebahn C, et al. Epithelialmesenchy-mal transition in colonies of rhesus monkey embryonic stem cells: a model for processes involved in gastrulation. Stem Cells 2005; 23: 805–16.
Fernando RI, Litzinger M, Trono P, et al. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest 2010; 120: 533–44.
Hamilton DH, Litzinger MT, Fernando RI, et al. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas. Semin Oncol 2012; 39: 358–66.
Latinkić BV, UmbhauerM, Neal KA, et al. The Xenopus Brachyury promoter is activated by FGF and low concentrations of activin and suppressed by high concentrations of activin and by paired-type home-odomain? Proteins Genes Dev 1997; 11: 3265–76.
Herrmann BG, Labeit S, Poustka A, et al. Cloning of the T gene required in mesoderm formation in the mouse. Nature 1990; 343: 617–22.
LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5.
Masi AT. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Com-mittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
Ihn H, Sato S, Fujimoto M, et al. Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. Clin Exp Immunol 1996; 105: 475–9.
Arakawa H, Jinnin M, Muchemwa FC, et al. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients. Exp Dermatol 2011; 20: 764–6.
Moriya C, Jinnin M, Yamane K, et al. Expression of matrix metalloproteinase-13 is controlied by IL-13 via PI3K/Akt3 and PKC-δ in normal human dermal fibroblasts. J Invest Dermatol 2011; 131: 655–61.
Ihn H, LeRoy EC, Trojanowska M. Oncostatin M stimulates transcription of the human α2(1) collagen gene via the Spl/Sp3-binding site. J Biol Chem 1997; 272: 24666–72.
Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008; 14: 1236–46.
Honda N, Jinnin M, Kajihara I, et al. TGF-β-mediated downreg-ulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 2012; 188: 3323–31.
Kajihara I, Jinnin M, Honda N, et al. Scleroderma dermal fibroblasts overexpress vascular endothelial growth factor due to autocrine transforming growth factor β signaling. Mod Rheumatol 2013; 23: 516–24.
Ghatak S, Bogatkevich GS, Atnelishvili I, et al. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β signaling in interstitial lung disease. J Biol Chem 2014; 289: 7856–72.
Yamamoto T, Takagawa S, Katayama I, et al. Animai model of sclerotic skin. I: Locai injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 112: 456–62.
Tanaka C, Fujimoto M, Hamaguchi Y, et al. Inducible costimu-lator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway. Arthritis Rheum 2010; 62: 1723–32.
Makino K, Jinnin M, Hirano A, et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J Immunol 2013; 190: 3905–15.
Guan Y, Mizoguchi M, Yoshimoto K, et al. MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res 2010; 16: 4289–97.
Kucich U, Rosenbloom JC, Shen G, et al. TGF-betal stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phos-pholipase C, protein kinase C-delta, and p38, butnoterkl/erk2. Arch Biochem Biophys 2000; 374: 313–24.
Kucich U, Rosenbloom JC, Shen G, et al. Requirement for geranylgeranyl transferase I and acyl transferase in the TGF-beta-stimulated pathway leading to elastin mRNA stabilization. Biochem Biophys Res Commun 1998; 252: 111–6.
Sun S, Sun W, Xia L, et al. The T-box transcription factor Brachyury promotes renai interstitial fibrosis by repressing E-cadherin expression. Celi Commun Signal 2014; 12: 76.
Acknowledgement
This study was supported in by a grant for NSFC. The funders had no rote in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Acknowledgement and disclosures. Conflicts of interest: The authors have no conflicts of interest to declare.
About this article
Cite this article
Teng, L., Yao, G., Gao, R. et al. TGF-β-mediated upregulation of brachyury contributes to constitutively up-regulated type I collagen expression in skin fibroblasts: possible role in systemic sclerosis. Eur J Dermatol 29, 359–365 (2019). https://doi.org/10.1684/ejd.2019.3607
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2019.3607